Candriam Equities L Biotechnology Class C USD CapRegister to Unlock Ratings |
Growth Of 1000 (GBP) | 31/01/2025 |
|
Annual Returns (GBP) | 31/01/2025 | |||||||
2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 31/01 | |
Price Return | -5.72 | 29.75 | 15.56 | -1.76 | 10.92 | 1.12 | 4.39 | 4.23 |
+/- Category | 2.25 | 9.55 | -10.41 | 7.27 | 18.76 | 2.40 | 7.31 | -0.29 |
+/- Category Index | -3.87 | 13.04 | -17.37 | -2.06 | 8.46 | -6.21 | 10.97 | -0.97 |
% Rank in Category | 35 | 10 | 72 | 35 | 2 | 31 | 21 | 62 |
Trailing Returns (GBP) | 12/02/2025 | ||
Total Returns | +/- Category | +/- Category Index | |
1 Day | 0.82 | 1.83 | 0.91 |
1 Week | -4.42 | -1.35 | -0.74 |
1 Month | 1.02 | 2.08 | 1.66 |
3 Months | -5.71 | 2.47 | 3.22 |
6 Months | -2.94 | -1.98 | 13.95 |
YTD | 1.63 | 0.55 | -1.35 |
1 Year | 2.37 | 2.79 | 9.32 |
3 Years Annualised | 10.10 | 6.52 | 2.13 |
5 Years Annualised | 5.39 | 1.93 | -0.33 |
10 Years Annualised | 7.14 | 1.08 | -0.30 |
Category: Sector Equity Biotechnology | |||
Category Index: Morningstar Gbl Biotechnology NR USD |
Quarterly Returns (GBP) | 31/01/2025 | |||
Quarter 1 | Quarter 2 | Quarter 3 | Quarter 4 | |
2024 | 3.73 | 2.73 | -0.52 | -1.52 |
2023 | -5.35 | -0.10 | -1.34 | 8.39 |
2022 | -4.00 | -0.05 | 13.44 | 1.91 |
2021 | -5.97 | 6.60 | 0.42 | -2.39 |
2020 | -5.34 | 25.01 | -5.87 | 3.75 |
|
Advertisement |